The ultrasound group of Siemens Medical Systems last month donated $110,000 in ultrasound equipment and technical training to Albania in an effort to support the United Nations Population Fund in its medical care of Kosovo refugees. The Issaquah,
The ultrasound group of Siemens Medical Systems last month donated $110,000 in ultrasound equipment and technical training to Albania in an effort to support the United Nations Population Fund in its medical care of Kosovo refugees. The Issaquah, WA-based group sent two Sonoline Versa ultrasound systems to Germany, where they were reconfigured to European electrical standards before being shipped to Tirana, Albania. The units were accompanied by a senior technical trainer from Issaquah who will install the systems and train healthcare providers in their use.
Siemens Ultrasounds parent, Siemens AG of Munich, Germany, is also making a donation, offering approximately $55,000 in medical equipment spare parts to the Macedonian Ministry of Health. Siemens AGs donation will be delivered to Skopje, Macedonia, and will be used primarily for x-ray departments and intensive care wards.
© 1999 Miller Freeman, Inc.All rights reserved.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.